0001209191-22-029135.txt : 20220516
0001209191-22-029135.hdr.sgml : 20220516
20220516162411
ACCESSION NUMBER: 0001209191-22-029135
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220512
FILED AS OF DATE: 20220516
DATE AS OF CHANGE: 20220516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zakrzewski Joseph S
CENTRAL INDEX KEY: 0001331852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40499
FILM NUMBER: 22929550
MAIL ADDRESS:
STREET 1: 509 WATERVIEW PLACE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662244
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455429901
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING A, SUITE 510
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 857-285-4140
MAIL ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING A, SUITE 510
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-12
0
0001662244
Cyteir Therapeutics, Inc.
CYT
0001331852
Zakrzewski Joseph S
C/O CYTEIR THERAPEUTICS, INC.
128 SPRING ST, BUILDING A, SUITE 510
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2022-05-12
4
P
0
743
1.61
A
133416
D
Common Stock
58671
I
See Footnote
Common Stock
149051
I
See Footnote
55,102 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
/s/ Adam M. Veness, as attorney-in-fact for Joseph Zakrzewski
2022-05-16